James Shin
Stock Analyst at Deutsche Bank
(0)
# 4908
Out of 5,317 analysts
21
Total ratings
11.11%
Success rate
-31.73%
Average return
Main Sectors:
Top Industries:
| Name | Action | Price Target | Current | % Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
GILD Gilead Sciences | Upgrades: Buy | 80 120 | 105.61 | 13.63% | 2 | Feb 18, 2025 | |
MRK Merck & Co | Downgrades: Hold | 128 105 | 78.17 | 34.32% | 2 | Feb 18, 2025 | |
LLY Eli Lilly | Maintains: Buy | 1025 1015 | 756.4 | 34.19% | 4 | Nov 4, 2024 | |
AMGN Amgen | Reiterates: Hold | 310 305 | 295.31 | 3.28% | 2 | Aug 7, 2024 | |
INCY Incyte | Maintains: Hold | 55 60 | 58.44 | 2.67% | 2 | Aug 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Hold | 53 45 | 49.91 | -9.84% | 2 | Jul 23, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 60 | 33.76 | 77.73% | 1 | May 23, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Hold | 150 | 176.78 | -15.15% | 1 | Nov 9, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Hold | 800 | 557.37 | 43.53% | 1 | Nov 9, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 25 | n/a | n/a | 1 | Nov 9, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 10 | 1.4 | 614.29% | 1 | Nov 9, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 12 | 0.58 | 1968.97% | 1 | Nov 9, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 80 70 | 0.72 | 9622.22% | 1 | Dec 12, 2022 |